Ameritas Investment Partners, Inc. - TRANSLATE BIO INC ownership

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$145,000
+51.0%
5,256
-9.5%
0.01%
+25.0%
Q1 2021$96,000
-10.3%
5,8080.0%0.00%
-20.0%
Q4 2020$107,000
+35.4%
5,8080.0%0.01%
+25.0%
Q3 2020$79,000
-1.2%
5,808
+29.9%
0.00%0.0%
Q2 2020$80,000
+233.3%
4,471
+83.5%
0.00%
+300.0%
Q1 2020$24,000
+20.0%
2,4360.0%0.00%0.0%
Q4 2019$20,000
-16.7%
2,4360.0%0.00%0.0%
Q3 2019$24,000
-22.6%
2,4360.0%0.00%0.0%
Q2 2019$31,000
+24.0%
2,4360.0%0.00%0.0%
Q1 2019$25,000
+316.7%
2,436
+224.8%
0.00%
Q4 2018$6,000
-25.0%
7500.0%0.00%
Q3 2018$8,0007500.00%
Other shareholders
TRANSLATE BIO INC shareholders Q3 2021
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 3,833,120$52,169,0008.78%
Copernicus Capital Management, LLC 227,719$3,099,0002.95%
FRAZIER MANAGEMENT LLC 2,182,789$29,708,0002.67%
Baupost Group 18,044,239$242,393,0002.62%
Prosight Management, LP 282,100$3,839,0001.83%
RTW INVESTMENTS, LP 3,745,286$50,973,0001.23%
GREAT POINT PARTNERS LLC 943,339$12,839,0001.16%
DAFNA Capital Management LLC 190,930$2,599,0000.84%
Endurant Capital Management LP 176,710$2,405,0000.71%
Artal Group S.A. 1,400,000$19,054,0000.46%
View complete list of TRANSLATE BIO INC shareholders